Notably, the proteasome activity is significantly suppressed in enzalutamide and abiraterone-resistant prostate cancer cells and the E3 ligase STUB1 and its binding chaperone protein HSP70 might control the AR-V7 proteostasis and confer the resistance. This evidence concerns the gene HSPA1A and prostate carcinoma.